Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 2
1916 1
1946 1
1947 1
1952 1
1958 1
1959 1
1962 1
1964 3
1965 2
1966 1
1967 5
1968 5
1969 7
1970 9
1971 7
1972 7
1973 9
1974 8
1975 10
1976 10
1977 13
1978 15
1979 8
1980 8
1981 20
1982 12
1983 15
1984 14
1985 7
1986 10
1987 14
1988 16
1989 23
1990 18
1991 22
1992 16
1993 20
1994 26
1995 27
1996 23
1997 16
1998 22
1999 16
2000 29
2001 31
2002 38
2003 42
2004 25
2005 23
2006 22
2007 30
2008 39
2009 36
2010 45
2011 36
2012 52
2013 54
2014 49
2015 42
2016 54
2017 52
2018 41
2019 45
2020 55
2021 25
Text availability
Article attribute
Article type
Publication date

Search Results

1,248 results
Results by year
Filters applied: . Clear all
Page 1
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. Among authors: dwyer jp. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, Murphy SA, Heerspink HJL, Zelniker TA, Dwyer JP, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Kato ET, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS, Raz I. Mosenzon O, et al. Among authors: dwyer jp. Lancet Diabetes Endocrinol. 2019 Aug;7(8):606-617. doi: 10.1016/S2213-8587(19)30180-9. Epub 2019 Jun 10. Lancet Diabetes Endocrinol. 2019. PMID: 31196815 Clinical Trial.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, Cherney DZI, Chertow GM, Douthat W, Dwyer JP, Escudero E, Pecoits-Filho R, Furuland H, Górriz JL, Greene T, Haller H, Hou FF, Kang SW, Isidto R, Khullar D, Mark PB, McMurray JJV, Kashihara N, Nowicki M, Persson F, Correa-Rotter R, Rossing P, Toto RD, Umanath K, Van Bui P, Wittmann I, Lindberg M, Sjöström CD, Langkilde AM, Heerspink HJL. Wheeler DC, et al. Among authors: dwyer jp. Nephrol Dial Transplant. 2020 Oct 1;35(10):1700-1711. doi: 10.1093/ndt/gfaa234. Nephrol Dial Transplant. 2020. PMID: 32862232 Free PMC article. Clinical Trial.
Hormonal Treatments for Major Depressive Disorder: State of the Art.
Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, Nemeroff CB, McDonald WM, Kalin NH; APA Council of Research Task Force on Novel Biomarkers and Treatments. Dwyer JB, et al. Am J Psychiatry. 2020 Aug 1;177(8):686-705. doi: 10.1176/appi.ajp.2020.19080848. Epub 2020 May 27. Am J Psychiatry. 2020. PMID: 32456504 Review.
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.
McKinnell JA, Dwyer JP, Talbot GH, Connolly LE, Friedland I, Smith A, Jubb AM, Serio AW, Krause KM, Daikos GL; CARE Study Group. McKinnell JA, et al. Among authors: dwyer jp. N Engl J Med. 2019 Feb 21;380(8):791-793. doi: 10.1056/NEJMc1807634. N Engl J Med. 2019. PMID: 30786196 Clinical Trial. No abstract available.
Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. Wagenlehner FME, et al. Among authors: dwyer jp. N Engl J Med. 2019 Feb 21;380(8):729-740. doi: 10.1056/NEJMoa1801467. N Engl J Med. 2019. PMID: 30786187 Clinical Trial.
1,248 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page